Time course of antiproteinuric effect of aliskiren in arterial hypertension associated with type 2 diabetes and microalbuminuria.

about

Time course of antiproteinuric effect of aliskiren in arterial hypertension associated with type 2 diabetes and microalbuminuria.

Item

http://www.wikidata.org/entity/Q44737055

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Time course of antiproteinuric ...... diabetes and microalbuminuria.

@en

Time course of antiproteinuric ...... diabetes and microalbuminuria.

@nl

type

Item

label

Time course of antiproteinuric ...... diabetes and microalbuminuria.

@en

Time course of antiproteinuric ...... diabetes and microalbuminuria.

@nl

prefLabel

Time course of antiproteinuric ...... diabetes and microalbuminuria.

@en

Time course of antiproteinuric ...... diabetes and microalbuminuria.

@nl

P1476

Time course of antiproteinuric ...... diabetes and microalbuminuria.

@en

P2093

Amedeo Mugellini

http://www.w3.org/2001/XMLSchema#string

Annalisa Zoppi

http://www.w3.org/2001/XMLSchema#string

Paola Preti

http://www.w3.org/2001/XMLSchema#string

Roberto Fogari

http://www.w3.org/2001/XMLSchema#string

Tiziano Perrone

http://www.w3.org/2001/XMLSchema#string

P2860

Glomerular permselectivity in early stages of overt diabetic nephropathy

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition

Aliskiren: the first renin inhibitor for clinical treatment

Cardiorenal end points in a trial of aliskiren for type 2 diabetes

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data.

Effect of direct renin inhibition on renal hemodynamic function, arterial stiffness, and endothelial function in humans with uncomplicated type 1 diabetes: a pilot study.

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

P304

371-384

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2013.772981

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pamela Maffioli

Giuseppe Derosa

P577

2013-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23414196

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes